[Antiviral agents].
D000212:Acyclovir / Q000627:therapeutic use; D000998:Antiviral Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D001972:Bromodeoxycytidine / Q000031:analogs & derivatives; D003841:Deoxycytidine / Q000031:analogs & derivatives / Q000627:therapeutic use; D003856:Deoxyuracil Nucleotides / Q000627:therapeutic use; D005128:Eye Diseases / Q000139:chemically induced / Q000188:drug therapy*; D006801:Humans; D007065:Idoxuridine / Q000627:therapeutic use; D009883:Ophthalmic Solutions; D014271:Trifluridine / Q000627:therapeutic use; D014740:Vidarabine / Q000627:therapeutic use; D014777:Virus Diseases / Q000188:drug therapy*
D000998:Antiviral Agents; D003856:Deoxyuracil Nucleotides; D009883:Ophthalmic Solutions; D003841:Deoxycytidine; D001972:Bromodeoxycytidine; C011288:ibacitabine; C033642:5-(2-bromovinyl)-2'-deoxyuridine-5'-triphosphate; D014740:Vidarabine; D007065:Idoxuridine; D014271:Trifluridine; D000212:Acyclovir
Les antiviraux.